Followers | 0 |
Posts | 1474 |
Boards Moderated | 0 |
Alias Born | 02/10/2022 |
Thursday, June 02, 2022 10:57:27 AM
https://eresearch.fidelity.com/eresearch/evaluate/news/basicNewsStory.jhtml?symbols=RPTX&pageno=&storyid=202206011618RTRSNEWSCOMBINED_FWN2XO0QP_1&provider=RTRSNEWS&product=COMBINED&
Recent RPTX News
- Repare Therapeutics Announces Updated Positive Safety and Tolerability Results from the Phase 1 MYTHIC Clinical Trial • Business Wire • 10/23/2024 10:05:00 AM
- Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-3467, a Polθ ATPase Inhibitor • Business Wire • 10/14/2024 11:05:00 AM
- Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination with Radiotherapy Treatment Presented at the ASTRO Annual Meeting • Business Wire • 09/30/2024 08:05:00 PM
- Repare Therapeutics Announces New Data Underscoring Need for Additional Treatment Solutions for Patients with Metastatic Gynecologic Cancers • Business Wire • 09/23/2024 11:05:00 AM
- Repare Therapeutics to Present Data from Phase 1/2 TRESR Clinical Trial Evaluating Camonsertib Monotherapy in Multiple Advanced Solid Tumors Harboring ATM Loss-of-Function at ESMO Congress 2024 • Business Wire • 09/13/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 08:15:31 PM
- Repare Therapeutics Announces Strategic Reprioritization to Focus on Broad Clinical Portfolio • Business Wire • 08/28/2024 08:05:00 PM
- Repare Therapeutics to Participate in Two Upcoming Investor Conferences • Business Wire • 08/27/2024 11:05:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/20/2024 04:15:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 01:06:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/06/2024 08:41:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:20:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:11:38 PM
- Repare Therapeutics Provides Business and Clinical Update and Reports Second Quarter 2024 Financial Results • Business Wire • 08/06/2024 08:05:00 PM
- Alberta Enterprise Corporation invests US$7.5 million into Amplitude precision medicine fund • PR Newswire (Canada) • 07/16/2024 01:00:00 PM
- Repare Therapeutics Announces Positive Initial Data at ESMO GI from Phase 1 MINOTAUR Trial Evaluating Lunresertib in Combination with FOLFIRI • Business Wire • 06/26/2024 02:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:05:54 PM
- Repare Therapeutics Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion of TRESR Clinical Trial • Business Wire • 06/10/2024 11:05:00 AM
- Repare Therapeutics Announces Fast Track Designation Granted by the FDA for Lunresertib in Combination with Camonsertib for the Treatment of Platinum-Resistant Ovarian Cancer • Business Wire • 06/04/2024 08:05:00 PM
- Repare Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 06/03/2024 08:05:00 PM
- Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024 • Business Wire • 05/29/2024 11:05:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/24/2024 08:06:52 PM
- Small Cap Massively Bid Following Key Q1 Earnings Beat • AllPennyStocks.com • 05/08/2024 02:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:15:55 PM
- Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results • Business Wire • 05/07/2024 08:05:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM